Tag: Carvykti
Johnson & Johnson: EU green light for Carvykti in multiple myeloma
Receive the value of the day for free every morning The data collected is essential for this processing and is intended for the relevant services of BFM Bourse and, where…
Johnson & johnson: Promising results for Carvykti
Receive daily value for free every morning The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its service…
J&J: promising results for Carvykti
(CercleFinance.com) – The Janssen Companies of Johnson & Johnson today announced that the Phase 3 CARTITUDE-4 study showed that Carvykti (Cilta-cel) reduced the risk of disease progression or death by…